查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1287627

不孕不育药物市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Infertility Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球不孕不育药物市场规模达到38亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到52亿美元，在2023-2028年期间表现出5.24%的增长率（CAGR）。

不孕不育药物是指用于治疗不孕不育和提高个人生殖健康的各种药物。它们要么是注射，要么是口服。一些常用的不孕不育药物包括促性腺激素、芳香酶抑制剂、选择性雌激素受体调节剂（SERM）、双胍类药物、排卵刺激剂、多巴胺激动剂和三环类抗抑郁药。它们的作用是刺激女性的排卵和卵巢的卵泡发育，而它们则有助于恢复男性的睾丸激素水平并提高精子的质量，从而实现怀孕。近年来，不孕不育药物在无法受孕的夫妇中得到了重视。

不孕不育药物的市场趋势：

不孕不育药物通过恢复个人促进受孕的能力，协助提高夫妻怀孕的机会。因此，不孕不育和流产的发生率上升是推动市场增长的主要因素。除此之外，各国政府采取了一些有利的倡议，以传播有关现有治疗方案的意识，正在催化对不孕不育药物的需求。此外，由于繁忙的工作安排、伴随的压力和生活方式的改变，慢性疾病的发病率有了明显的增加，如癌症、肥胖、糖尿病、甲状腺、多囊卵巢综合症（PCOS）和更年期障碍。与此同时，由于延迟怀孕、晚婚和不健康的生活习惯，如过度饮酒、吸毒和吸烟，导致生育率下降，正在加速产品的采用率。此外，一些主要参与者正在从事研究和开发（R&D）活动，以推出疗效更好、剂量要求更低、副作用更少的创新型不孕不育药物。此外，用于开发这些药物的公共资金不断增加，各监管机构对药物的审批速度加快，这些都推动了市场的增长。其他因素，包括对仿制药需求的升级、医疗基础设施的改善、消费者支出能力的提高、快速城市化和技术进步，也为市场增长提供了积极的推动力。

本报告回答的关键问题：

  • 迄今为止，全球不孕不育药物市场的表现如何，在未来几年将如何表现？
  • COVID-19对全球不孕不育药物市场的影响是什么？
  • 主要的区域市场是什么？
  • 基于药物类别的市场细分是什么？
  • 基于给药途径的市场细分是什么？
  • 基于分销渠道的市场分布情况如何？
  • 基于终端用户的市场细分是什么？
  • 该行业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球不孕不育药物市场的结构是什么，谁是主要参与者？
  • 该行业的竞争程度如何？

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球不孕不育药物市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按药物类别分類的市场

  • 促性腺激素
    • 市场趋势
    • 市场预测
  • 芳香化酶抑制剂
    • 市场趋势
    • 市场预测
  • 选择性雌激素受体调节剂(SERMs)
    • 市场趋势
    • 市场预测
  • 双胍类药物
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第7章 ：按给药途径分類的市场

  • 口服
    • 市场趋势
    • 市场预测
  • 静脉注射
    • 市场趋势
    • 市场预测
  • 皮下注射
    • 市场趋势
    • 市场预测
  • 肌内注射
    • 市场趋势
    • 市场预测

第8章：按分销渠道分類的市场

  • 医院药房
    • 市场趋势
    • 市场预测
  • 零售药店
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按终端用户分類的市场

  • 男性
    • 市场趋势
    • 市场预测
  • 女性
    • 市场趋势
    • 市场预测

第十章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十一章 ：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十二章 ：价值链分析

第十三章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十四章：价格分析

第十五章 ：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • Abbott Laboratories
    • Bayer AG
    • Ferring Pharmaceuticals
    • Livzon Pharmaceutical Group Inc.
    • Mankind Pharma
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Theramex
Product Code: SR1623A385_Report

The global infertility drugs market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.24% during 2023-2028.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

Gonadotropin

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Others

Breakup by Route of Administration:

Oral

Intravenous

Subcutaneous

Intramuscular

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by End User:

Male

Female

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report:

  • How has the global infertility drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global infertility drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global infertility drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Infertility Drugs Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Drug Class

  • 6.1  Gonadotropin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Aromatase Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Selective Estrogen Receptor Modulators (SERMs)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Biguanides
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7   Market Breakup by Route of Administration

  • 7.1  Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Subcutaneous
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Intramuscular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Distribution Channel

  • 8.1  Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Male
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Female
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  Ferring Pharmaceuticals
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  Livzon Pharmaceutical Group Inc. 
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5  Mankind Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6  Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7  Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8  Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9  Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10  Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Theramex
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
  • Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
  • Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Infertility Drugs Market: Competitive Structure
  • Table 8: Global: Infertility Drugs Market: Key Players